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Abstract 
The classical conditioning paradigm of fear learning has spawned a number of experimental 
variations for the explanation of posttraumatic stress disorder (PTSD) etiology. These 
paradigms include extinction learning and recall, fear inhibition, fear generalization, and 
conditioned avoidance. As such, each of these paradigms have significant applications for 
understanding the development, maintenance, treatment, and relapse of the fear-related 
features of PTSD. In the present review, we describe each of these conditioning-based 
paradigms with reference to the clinical applications, and supported by case examples of a 
patient with severe PTSD symptoms. We also review the neurobiological models of 
conditioning and extinction in animals, psychiatrically healthy humans, and PTSD patients, 
and discuss the current balance of evidence suggesting a number of biological, behavioral, 
and cognitive mechanisms/moderators of the conditioning and extinction process in 
experimental and clinical contexts. 
 
Keywords: Posttraumatic stress disorder; Conditioning; Extinction; Avoidance; 
Generalization; Exposure therapy 
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1. Introduction 
As many as 70% of the population may experience a traumatic event at some point in their 
lifetime (Resnick et al., 1993), and a small subset of these individuals will go on to develop 
symptoms of posttraumatic stress disorder (PTSD). Studies in military samples show lifetime 
prevalence rates of 19% due to war-related trauma, and lifetime PTSD rates in civilians can 
vary dramatically by country and trauma type (Karam et al., 2014; Kessler et al., 1995), and 
can be as high as 15% (Kessler et al., 1995; Ramchand et al., 2010). PTSD can be a chronic 
and debilitating condition resulting in significantly reduced quality of life, and comorbidity 
with depression and substance abuse. Hallmark symptoms of the disorder typically include 
distressing intrusive memories, avoidance of trauma reminders, hyperarousal, and negative 
alterations in cognition and mood (DSM-5; American Psychiatric Association, 2013). A 
primary treatment technique for PTSD (as well as other anxiety disorders with specific 
triggers or cues) is prolonged exposure therapy. During exposure therapy, the client is 
repeatedly exposed to the feared stimulus or situation via a series of in vivo exposures or 
narrative/mental imagery-based tasks. This treatment technique largely draws on, and is 
influenced by, the mechanisms of fear conditioning and extinction (Rothbaum and Davis, 
2003; Yehuda et al., 2015b), based on Pavlov’s (1927) classical conditioning theory. As the 
natural response to trauma exposure is recovery (Bryant, 2003), a current argument is that 
impairments in fear conditioning and extinction processes contribute to the ongoing 
persistence or relapse of fear-related symptoms of PTSD (Briscione et al., 2014; Mineka and 
Oehlberg, 2008; Pitman et al., 2012; Zuj et al., 2016b). Indeed, a number of different 
conditioning paradigms have been developed over the past few decades that provide unique 
explanations for different clinical situations of posttraumatic stress.  
Variations in fear conditioning paradigms (such as tests of extinction recall, 
generalization, and avoidance) all present unique translational explanations for the 
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development, persistence, treatment, and relapse of the fear-related features of PTSD 
(Norrholm and Jovanovic, 2018). The current review describes the specific translational 
relevance of each of the various fear learning paradigms for clinical situations. Although 
these paradigms carry important implications for a number of psychiatric conditions, this 
review focuses on evidence from research in PTSD populations. To further highlight the 
clinical relevance of this field of experimental psychopathology, we illustrate the 
translational nature of many of these paradigms with anonymized real-world examples from 
clinical patients with PTSD.1 The importance of conditioning paradigms for various clinical 
scenarios is highlighted by recent evidence of a correlation between fear extinction 
performance and the success of laboratory- and clinic-based treatment approaches (Ball et al., 
2017; Forcadell et al., 2017; Waters and Pine, 2016), supporting the idea that extinction is a 
key process in exposure-based treatments for anxiety disorders (Pitman et al., 2012). 
 PTSD is a broad and dynamic condition, often characterized by considerable 
individual differences in symptom presentation. In addition to hallmark symptoms of 
intrusive memories, avoidance behaviors, and hyperarousal, PTSD can also be characterized 
by symptoms of anger (McHugh et al., 2012), emotional numbing (Felmingham et al., 2014), 
dissociation (Armour et al., 2014), and sleep disturbances (Germain, 2013). Although this 
review acknowledges the wide-range of symptoms that can present in PTSD, we will be 
focusing on the fear-related features of PTSD, and the critical relevance of experimental fear 
conditioning paradigms (Jovanovic and Norrholm, 2016). In doing so, we will begin with a 
brief review of the translational cortical models of fear processing from animal research to 
humans with and without anxiety disorders, followed by a discussion of conditioning 
paradigms and their relevance for PTSD development, treatment, and relapse. Finally, we 
                                                        
1 Anonymous patient statements are provided by the authors through clinical encounters with previously 
traumatized individuals presenting with signs and symptoms of PTSD. 
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conclude with a brief discussion of additional factors known to mediate/moderate the 
extinction process. Throughout this review, we provide anonymous reports from clients to 
illustrate the significance of each of these experimental paradigms for explaining PTSD 
symptomatology. This review is not aimed at identifying a ‘common practice’ for fear 
conditioning methodologies (for a thorough review of design considerations in human fear 
conditioning, see Lonsdorf et al., 2017), but is intended to highlight the relevance of fear 
conditioning paradigms for various clinical situations.  
 
1.1. Fundamental Concepts in Fear Conditioning and Extinction 
 Fear conditioning and extinction is based on Pavlov’s (1927) classical conditioning 
theory of behavioral learning. This theory argues that a previously neutral stimulus becomes 
a conditioned stimulus (CS) through repeated pairings with an aversive event (e.g., a mild 
electric shock (Zeidan et al., 2012), or a sudden blast of air to the larynx (Norrholm et al., 
2006)). Through association, the CS elicits a conditioned response (CR) in the absence of the 
unconditioned stimulus (US). Extinction occurs when this threat response subsides through 
repeated presentations of the CS in the absence of the US. Irrespective of the timing of 
extinction relative to conditioning, extinction does not appear to erase or override the 
conditioning memory (Archbold et al., 2010), but instead results in the formation of a new 
inhibitory memory to prevent the expression of the CS-US fear association (Bouton, 2002; 
Delamater, 2004; Myers and Davis, 2002). The conditioned response may, however, return 
due to certain environmental or contextual factors (e.g., unsignaled US presentations termed 
reinstatement; the passage of time termed spontaneous recovery). Consistent evidence shows 
fear extinction learning and/or memory to be impaired in individuals with PTSD (e.g., 
Blechert et al., 2007; Norrholm et al., 2015; Norrholm et al., 2011).  
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 Conditioned fear responses are typically quantified by a variety of physiological and 
behavioral measures, among the most common of which are skin conductance response 
(SCR), acoustic startle, and self-reported US-expectancy ratings (Briscione et al., 2014). Skin 
conductance refers to the electrodermal activity of the sweat glands – a direct measure of 
sympathetic arousal (Boucsein, 1992). Studies have reliably found increased SCRs to the US-
reinforced CS+ during fear acquisition, compared to a second CS that is never reinforced, 
termed the CS- (e.g., Orr et al., 2000; Phelps et al., 2004; Zuj et al., 2016a). Alternatively, 
fear-potentiated startle (FPS), or the relative increase in the frequency or magnitude of the 
acoustic startle response in the presence of a cue (CS+) that has been paired with an aversive 
outcome (US), reflects an automatic behavioral startle response to aversive stimuli that is a 
widely used translational tool to model fear and anxiety (Davis, 1992; Jovanovic and 
Norrholm, 2016). Similar to SCR, considerable research has found FPS to reliably increase in 
relation to the CS+ as compared to a participant’s own baseline acoustic startle response and 
relative to the CS- (e.g., Glover et al., 2011; Guthrie and Bryant, 2006; Norrholm et al., 
2015). Indeed, Guthrie and Bryant (2006) found increased pre-trauma startle responses 
during fear extinction to be a significant predictor of posttraumatic stress reactions in trainee 
firefighters. Fear-potentiated startle, rather than SCR, has also been argued to be a more 
useful translational tool for neuroscience due to clear cortical relationships with the amygdala 
(Davis and Whalen, 2001; Glover et al., 2011; Kindt and Soeter, 2013). It is important to note 
that psychophysiologically based fear acquisition/extinction methods, including those 
discussed in the present review, have been identified by the United States National Institute 
of Mental Health (NIMH; 2016) Research Domain Criteria (RDoC) workgroup as a 
recommended negative valence system task paradigm for assessing acute fear.  
 In addition to SCR and FPS, self-report US-expectancy ratings are considered a valid 
measure of human fear extinction and threat expectancy (Boddez et al., 2013), and are widely 
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used in conjunction with psychophysiological measures (Kindt and Soeter, 2013; Norrholm 
et al., 2011; Vervliet et al., 2007; Zuj et al., 2017b). Further, increased US-expectancy ratings 
during fear extinction in Dutch soldiers prior to deployment was found to be a significant 
predictor of PTSD symptoms post-deployment (Lommen et al., 2013). Studies have also 
shown different patterns of conditioning and extinction for different response measures. For 
example, Blechert et al. (2008) have found extinction learning to be very rapid in SCR 
amplitude data, and slower in US-expectancy ratings, suggesting a disparity between 
psychophysiological arousal and cognitive threat expectancy. 
 
1.2. From Rodents to Humans: Understanding the Cortical Networks of Fear 
 Biological fear networks are remarkably translational, with initial animal research in 
rodents informing our understanding of the cortical fear networks in humans (for reviews, see 
Myers and Davis, 2007; Pitman et al., 2012). The amygdala is the premier subcortical 
structure in activating sympathetic threat systems (LeDoux, 2000), based on excitatory or 
inhibitory projections from prefrontal and hippocampal networks. In short, sensory 
recognition of environmental (or internal) threat activates two systems simultaneously. Threat 
is recognized by cognitive pathways and subjectively labeled (and experienced) as fear, while 
efferent cortical projections from the amygdala increase arousal in biological and 
physiological systems required for a response to the threat (LeDoux and Brown, 2017). An 
important discussion relevant to this review has been raised by LeDoux (2014) with respect 
to the meaning of the term ‘fear’ as it applies to the processes of threat detection in lower 
mammals and the emotional state of fear in humans. For the sake of this review and to 
maintain consistency with the expansive corpus of literature in this area, we will use the 
overarching term ‘fear’ across the translational bridge of our discussions. While the amygdala 
is important in activating these biological and physiological systems, this is contingent on the 
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information relayed from certain cortical and subcortical systems. Different neural structures 
play markedly different roles in the excitation or inhibition of the amygdala in various 
situations, and these relationships are summarized in Figure 1. 
 
[INSERT FIGURE 1 ABOUT HERE] 
 
Rodent research shows that the amygdala receives inhibitory projections from the 
infralimbic cortex based on understanding of CS-US contingencies, with increased 
infralimbic cortical activation associated with extinction learning (Barrett and Gonzalez-
Lima, 2018) and extinction recall (Milad and Quirk, 2002). While extinction learning is 
associated with greater activation of inhibitory networks between the infralimbic cortex and 
basolateral amygdala, selective inhibition of this network impairs extinction learning 
(Bloodgood et al., 2018; Laurent and Westbrook, 2009; Milad and Quirk, 2002; Milad et al., 
2004; Quirk et al., 2000). Alternatively, the prelimbic cortex acts in opposition to the 
infralimbic cortex, whereby greater activation is associated with greater conditioned 
responding and poorer extinction (Burgos-Robles et al., 2009; Fenton et al., 2014; Sierra-
Mercado et al., 2011) which is specific for learned, but not innate threat responding 
(Corcoran and Quirk, 2007). In addition, the hippocampus plays a crucial role in contextual 
processing, with lesion studies showing greater freezing in safe as well as dangerous contexts 
(reviewed in Maren et al., 2013). 
 Similarly in humans, the amygdala appears to play a key role in the excitation (or 
inhibition) of biological and physiological systems for threat responding (Cheng et al., 2006; 
Cheng et al., 2003; Cheng et al., 2007; Duvarci and Pare, 2014; Knight et al., 2004; LaBar et 
al., 1998; Morris and Dolan, 2004; Pare and Duvarci, 2012), with Sehlmeyer et al. (2011) 
showing amygdala activity increasing towards the end of fear acquisition and then 
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subsequently decreasing throughout extinction learning. These findings demonstrate the 
excitatory and inhibitory processes of the amygdala during threat responding and the 
extinction of threat responses. Further, the infralimbic and prelimbic cortices in rodents 
appear to be functionally analogous to the ventromedial prefrontal cortex (vmPFC) and 
dorsal anterior cingulate cortex (dACC) in humans, respectively. Specifically, vmPFC 
activation inhibits amygdala projections and subsequent threat responding (Milad et al., 2006; 
Milad et al., 2007b; Motzkin et al., 2014), while activation in the dACC results in greater 
amygdala activation, encouraging conditioned responding (Cheng et al., 2003; Knight et al., 
2004; Linnman et al., 2011; Milad et al., 2007a). Further, the hippocampus only appears to 
show greater activation in conditioning paradigms with multiple contexts and various 
contingencies for extinction (Lang et al., 2009; Milad et al., 2007b), with non-contextual 
conditioning studies showing no modulation of the hippocampus (Phelps et al., 2004).  
Further support for the above neurocircuitry of emotional fear processing has been 
found in populations with PTSD. For instance, greater dACC activity in PTSD has been 
associated with poorer extinction learning (Rougemont-Bücking et al., 2011) and extinction 
recall (Milad et al., 2009). Shvil et al. (2014), however, found this effect only in men with 
PTSD. Furthermore, Sripada et al. (2013) found a relationship between avoidance symptoms 
in PTSD and greater activity in the amygdala, vmPFC and hippocampus, among other 
emotion-related regions (i.e., insula and dorsomedial PFC). 
 
2. Paradigms and Phases of Associative Fear Learning 
In this section, we discuss the clinical relevance of the different experimental models 
based on a fear conditioning framework. As such, this review discusses (1) 
acquisition/conditioning as an analogue for the development of post-traumatic stress 
symptoms; (2) extinction learning as an influential explanation for the natural recovery of 
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symptoms, but also for the maladaptive persistence of symptoms; (3) extinction 
memory/recall paradigms as a model for treatment resistance and symptom remission; (4) 
return of fear manipulations for the relapse of symptoms post-treatment and delayed-onset of 
PTSD symptoms; (5) fear inhibition as a model for the inability to transfer learned safety 
contingencies; (6) reversal learning for the new learning of attributing positive valences to 
previously negative stimuli, and vice versa; (7) instrumental avoidance paradigms and 
maladaptive attempts to avoid stressful fear symptoms; and (8) the generalization of fear 
responses to benign stimuli that were not present during the traumatic event. In the final 
section, we acknowledge a number of genetic, biological, behavioral, and cognitive factors 
that have been shown to moderate/mediate some of these processes. 
 
2.1. Fear Acquisition/Conditioning 
 Fear acquisition refers to the initial associative learning process of the CS-US 
relationship. During fear acquisition in experimental settings, a neutral stimulus (e.g., colored 
geometric shapes, lights) is paired with the US (e.g., mild electric shock, aversive airblast). 
Through repeated pairings, the CS+ comes to predict the US and elicits a distinct fear 
response when compared to a safety signal (a similar stimulus never paired with the US, 
termed the CS-). Studies are somewhat mixed regarding levels of differential conditioning 
between PTSD and traumatized or non-traumatized control groups. PTSD-specific effects in 
fear acquisition are mixed, with some studies finding elevated psychophysiological 
responding to the safety cue (Acheson et al., 2015; Handy et al., 2018; Jovanovic et al., 2010; 
Peri et al., 2000), greater CS+/- discrimination (Blechert et al., 2007; Orr et al., 2000), or no 
differences at all (Glover et al., 2012). 
Despite these mixed findings for PTSD-specific patterns of responding during fear 
acquisition, a recent meta-analysis by Duits et al. (2015) found a small effect that patients 
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with anxiety disorders display increased fear expression to the CS- during fear acquisition. 
As discussed by Duits et al. (2015), this finding can be interpreted in one of two ways: (1) 
individuals with PTSD may have a greater propensity to generalize fear to similar neutral 
stimuli, and (2) this effect may be reflective of impaired inhibition processes. Both are 
equally likely explanations, and greater fear expression to the CS- during acquisition is likely 
to be due to a combination of generalization and inhibitory processes. Indeed, fear 
generalization has been described as “balancing excitation versus inhibition” (Dymond et al., 
2015, p.565), and will be discussed in greater detail below. 
Translationally, the fear acquisition phase is considered a laboratory model for trauma 
exposure. A traumatic event acts as a naturally occurring US that evokes unconditioned 
responses of intense arousal and fear. Indeed, there is consistent evidence of heightened 
physiological arousal (as indexed by acoustic startle and heart rate responses) in the acute 
aftermath of trauma as a significant predictor of increased posttraumatic stress at follow-up in 
motor vehicle accident survivors (Bryant et al., 2000), firefighters (Guthrie and Bryant, 
2005), and assault victims (Griffin, 2008). Further, patients with PTSD present with elevated 
physiological arousal at rest (Peri et al., 2000), and greater fear-potentiated startle to the CS+ 
during late acquisition is associated with high levels of re-experiencing and hyperarousal 
symptoms (Norrholm et al., 2011). These studies suggest that individuals with PTSD show 
heightened physiological arousal in the acute phase post-trauma, which is argued to reflect 
the propensity for stronger unconditioned responses (Bryant et al., 2000; Shalev et al., 1998). 
In turn, this heightened peri- and post-traumatic arousal may manifest into greater fear-
related symptoms, namely re-experiencing and hyperarousal (Norrholm et al., 2011). 
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Although fear conditioning can provide a theoretical explanation for the development 
of the fear-related clinical features of PTSD, it cannot however, fully explain the persistence 
of these symptoms, or explain why some individuals do not develop PTSD. Indeed, a study 
by Bryant et al. (2013) found that during 3-, 12-, and 24-month follow-ups, many individuals 
moved between symptom-free, sub-syndromal, and clinical PTSD classifications. 
Specifically, the rates of PTSD at each time-point remained relatively stable, however 
participant membership fluctuated between the different diagnostic categories at each time-
point. In support, many individuals with severe PTSD symptoms in the weeks following a 
trauma recover in the following months (for a review, see Bryant, 2003). Due to the 
normative response to trauma being recovery, and the dynamic trajectory of PTSD onset, 
Box 1. Clinical vignette: Fear Acquisition 
 
John is a 33-year old, male U.S. Air Force veteran who was deployed to 
the Middle East three times as a flight support officer. Following his 
deployments, John remained on Active Duty serving at a stateside joint 
military installation for three years. As is common with many service 
members, John interacted with his colleagues both during their tours of 
duty and while off duty at various social events. A year after his military 
service ended, John came to the PTSD clinic with symptoms of PTSD 
and sought treatment for these symptoms as well as co-morbid 
depression and alcohol abuse. During his initial assessment, John 
reported a significant traumatic event that occurred during the previous 
Christmas holiday season in which a friend and colleague had committed 
suicide by self-inflicted gunshot wound in John’s presence at his friend’s 
home. John reported significant distress and anxiety, both emotional and 
physical in nature, in the presence of sirens and flashing lights; 
posttraumatic sequelae that developed at the time of the traumatic event 
as John remained on the scene as first responders arrived and tended to 
his recently deceased friend and colleague. Exposure to sirens and 
flashing lights on police, fire, and rescue vehicles repeatedly evoked 
classical symptoms of panic and anxiety in John including racing heart, 
excessive perspiration, shallow, rapid breathing, as well as nausea and 
vomiting. In addition to these somatic features, John also found himself 
becoming emotionally upset with bouts of sadness and crying both during 
and in the immediate aftermath of exposure to sirens and flashing lights. 
Per John’s report, these physical and emotional responses to cues 
related to emergency services subsided after he was removed from the 
situations for an extended period of time, often in the safety of his home.    
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persistent fear-related PTSD symptoms are likely due to mechanisms of impaired extinction, 
avoidance, and/or inhibition, rather than conditioning. 
 It is important to note here that we do not suggest that PTSD is a “fear-conditioning 
disorder” as its heterogeneous presentation spans several neurobiological, cognitive, 
emotional, and social domains including frequently observed guilt, shame, anger, and 
irritability. These symptoms are likely mediated by cortical and subcortical (e.g., striatal) 
brain regions that lie outside of the limbic circuitry implicated in fear learning (McHugh et 
al., 2012; Briscione et al., 2014; Norrholm and Jovanovic, 2018).   
 
2.2. Fear Extinction Learning 
 Fear extinction occurs following fear acquisition (either immediately, or following a 
delay), whereby the CS+ is repeatedly presented without the US. Over time, this results in a 
reduction in conditioned fear responses to the CS+, until there is minimal discriminability 
between the CS+ and CS-. It is important to note here that in experimental situations, most 
participants extinguish conditioned responses (for a discussion of non-extinguishers, see 
Norrholm et al., 2008), however, it is the rate/pattern of extinction that is of most interest. 
Compared to trauma-exposed and non-exposed controls, individuals with PTSD tend to show 
slower rates of extinction learning (Acheson et al., 2015; Blechert et al., 2007; Zuj et al., 
2017b; Zuj et al., 2017c), or greater physiological arousal during extinction (Fani et al., 2012; 
Norrholm et al., 2011; Orr et al., 2000; Peri et al., 2000).  
 One way in which impaired fear extinction learning can present in PTSD is fear load. 
Fear load refers to a pattern of fear expression whereby individuals with PTSD display 
greater fear expression in the early phases of extinction learning, compared to control groups 
(Norrholm et al., 2015; Norrholm et al., 2011), and is argued to be an intermediate phenotype 
of PTSD symptom development. That is, PTSD participants display greater levels of fear at 
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the beginning of extinction learning, compared to controls. Indeed, fear load draws a number 
of parallels with risk factors of PTSD, such as genetics (Norrholm et al., 2013) and sex 
hormones (Glover et al., 2012). Fear load is also associated with an increased attentional bias 
to threat (Fani et al., 2012), which has been found to be specific to PTSD in Australian 
soldiers, compared to soldiers with a mild traumatic brain injury without PTSD (Zuj et al., 
2017a). Further, Galatzer-Levy et al. (2017) identified increased fear load to be a specific 
trajectory of acquisition and extinction, characterized by high levels of fear-potentiated startle 
during acquisition and extinction, and little reduction in startle during extinction. This 
trajectory appeared to be distinct from other trajectories characterized by complete extinction 
of fear-potentiated startle (Galatzer-Levy et al., 2017). It is likely that this non-extinction 
trajectory may be associated with treatment-resistant PTSD symptoms. 
Trauma-focused cognitive behavioral therapies, such as prolonged exposure therapy, 
are considered to work via fear extinction mechanisms to reduce the distress associated with 
trauma-related thoughts and behaviors (McLean and Foa, 2011; Rauch et al., 2012; Yehuda 
et al., 2015b). During prolonged exposure therapy, the patient is gradually exposed to 
reminders of the traumatic event, resulting in increased physiological arousal and anxiety. 
Over the course of treatment sessions, recounting the traumatic event produces lower levels 
of fear and anxiety, much the same way this process occurs in experimental extinction 
sessions. Although prolonged exposure therapy is considered the gold standard of treatment 
for PTSD, reports indicate that there are large dropout rates due to the huge levels of distress 
caused by initial stages of treatment (Schnurr et al., 2007; Simmons et al., 2013; Yehuda et 
al., 2015a). This elevated level of distress in the beginning of exposure therapy can be 
conceptualized as fear load, whereby reminders of the traumatic event are initially met with 
intense physiological hyperarousal. 
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2.3. Fear Extinction Recall 
 In clinical settings, the extinction of a distressing conditioned response to emotional 
trauma reminders occurs in two ways: within-session (as discussed above), and between-
session. Regarding the latter, symptom reduction during a session of exposure-based therapy 
needs to carry over into subsequent sessions for long-term symptom management. In 
laboratory settings, this involves assessing the recall of fear extinction in the days following 
extinction learning (e.g., Milad et al., 2008). Multi-day conditioning, extinction, and 
extinction recall paradigms have found deficient between-session recall of extinction in 
Box 2. Clinical vignette: Fear Extinction Learning 
 
The patient introduced in Box 1, John, was assigned to prolonged 
exposure treatment that consisted of weekly sessions with a therapist 
as well as between-session in vivo exposure exercises according to the 
clinical protocol published by Foa and colleagues (2007). The session-
by-session procedures included as part of this type of treatment will not 
be reviewed in detail here but the reader is referred to the latter work of 
Foa and others. During his treatment sessions, John repeatedly 
recounted his traumatic experience, in the safety of the clinical space, 
having witnessed the suicide of a friend and fellow service member. 
This included detailed descriptions of the sensory and emotional 
experiences that encompassed this distressing event. As is typical with 
this type of treatment, John reported his Subjective Units of Distress 
(SUDS) level at regular intervals during the sessions as well at the 
beginning and end of his recollections. John and his therapist created a 
hierarchy of cues, places, and situations in which to be exposed during 
his in vivo exposures. This was done in a graded fashion with the 
patient “building up” to the contexts and situations that are reported to 
be most distressing. For John, this hierarchy involved moving from 
limited exposure to emergency-related sounds played through audio 
devices and handheld flashing lights, as are often seen on emergency 
vehicles before progressing to exposures in and around first responder 
facilities such as fire and police facilities. John did well with this 
treatment regimen as evidenced by clinician- and self-reported 
symptom inventories, self-reported reductions in his SUDS level over 
the course of his 8-week course of therapy, and increased exposure to 
situations in close proximity to rescue vehicles. By the end of treatment, 
John reported an increased quality of life, reduced alcohol 
consumption, and re-engagement with many of the activities that he 
had long avoided.  
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participants with PTSD, with no impairments in acquisition or within-session extinction 
(Milad et al., 2008; Milad et al., 2009; Shvil et al., 2014). Similarly, these findings have also 
been found in patients with obsessive-compulsive disorder, compared to controls (Milad et 
al., 2013). Furthermore, recent evidence shows that adolescents, who are at greater risk for 
the development of anxiety disorders, show impaired extinction recall compared to adults 
(Ganella et al., 2017b) and this appears to be linked to reduced activity in regions of the 
prefrontal cortex (Ganella et al., 2017a; Ganella et al., 2017b). Recent evidence also suggests 
that transcranial magnetic stimulation of the PFC enhances extinction recall (Raij et al., 
2017), further supporting the inhibitory function of the vmPFC on amygdala circuits. 
Extinction recall paradigms are an important experimental model for the maintenance of 
symptom reduction following sessions of exposure therapy. 
 
2.4. Return of Fear Following Extinction Learning 
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 As described previously in this review, conditioned fear memories (e.g., CS-US 
associations) are not erased following extinction learning and can be elicited through the 
processes of spontaneous recovery (after the passage of time; Pavlov, 1927), reinstatement 
(following the unsignaled presentation of the US without the CS; Rescorla and Heth, 1975), 
or renewal (following a change in context from the extinction learning environment; Bouton 
and Bolles, 1979). The clinical analogues of the laboratory phenomena of spontaneous 
recovery, reinstatement, and renewal are time elapsed since the conclusion of extinction-
based exposure therapy, exposure to a stressful life event, and experiences within contexts 
different from that within which therapy occurred, respectively (Norrholm, 2012). 
Box 3. Clinical vignette: Return of Fear 
 
Patient John successfully completed prolonged exposure therapy for his 
PTSD symptoms and returned to many of his daily activities including steady 
employment as an air traffic support technician at the local airport. He was 
not seen in the PTSD clinic for 18 months after which time he returned to the 
clinic with relapse of his PTSD symptoms. He again reported physical and 
emotional reactivity in the presence of emergency response-related cues. 
During his return assessment visit, John disclosed that he had recently 
undergone short-term, invasive treatment for a localized, benign tumor in his 
abdomen. He stated that his PTSD symptoms returned shortly after his 
discharge from the hospital. Per his report, his exposure to the various 
medical clinics and procedures reminded him of his traumatic experience 
with his colleague’s suicide and that these intrusive memories were coupled 
with his own thoughts of death, dying, and mortality. During the few days in 
which he waited for the results of his biopsy and in the days leading up to his 
surgery, he felt as if his life was endangered by the new medical diagnosis. 
These thoughts and feelings evoked visceral, panic-like symptoms. Clinically 
speaking, a significant medical crisis can precipitate a relapse of PTSD 
symptoms. In experimental fear learning terms, this is analogous to 
reinstatement of fear when a successfully extinguished participant is 
presented with the fear-eliciting unconditioned stimulus in the absence of the 
cues previously paired to the US. It is also important to note here, that 
John’s relapse may also be partially explained by a generalization of fear, 
that he previously acquired to emergency response-related cues, to the cues 
to which he was exposed during his hospital stay. John underwent a brief, 4-
week course of exposure and talk therapy after which time he reported a 
reduction in his relapsed PTSD intrusive and hyperarousal symptoms.   
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2.5. Fear Inhibition 
 Fear inhibition is related to fear extinction with a notable exception being that 
inhibition paradigms typically compare subject responses to a reinforced “danger” cue (e.g., 
CS+) with responses to a non-reinforced “safety” cue (e.g., CS-). Fear extinction, by 
definition, refers to a decrease in fearful responding to a previously reinforced CS+ following 
a change in the experimental contingency (i.e., presentation of the same CS is no longer 
followed by an aversive outcome). Fear inhibition has been reliably investigated by 
Jovanovic and colleagues (2010) using psychophysiological indices previously described 
using a learning paradigm termed AX+/BX-. As part of this approach, a neutral stimulus 
(termed the X cue) is paired with a cue (termed the A cue) that is paired with an aversive 
airblast US. This compound is referred to as the AX+ compound and its presentation is 
repeatedly followed by the US. In addition, a second cue (termed the B cue) that is not paired 
with the US is presented with the same neutral X cue, and this compound is referred to as 
BX-. Subsequently, the previously reinforced A cue and non-reinforced B cue are paired 
together (termed the AB compound) and presented to determine the degree to which the 
inhibitory properties of the B cue are transferred to the excitatory A cue. Healthy controls 
routinely show this transfer of inhibition (Jovanovic et al., 2005). In PTSD patients, however, 
a failure of transfer of inhibition has been reported by this group as evidenced by similar 
levels of fear responding to both the excitatory AX compound and the inhibition test 
compound AB (Jovanovic et al., 2009). These results suggested that PTSD may be related to 
an impairment in transferring learned safety (a goal of treatment for trauma-, stressor-, and 
anxiety-related disorders). 
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2.6. Reversal Learning 
 Fear learning, as assessed by acquisition and extinction paradigms, is context-
dependent and conditioned fear responses emerge in the presence of both discrete cues and 
Box 4. Clinical vignette: Fear Inhibition and Reversal Learning 
 
Sam was a 35 year old U.S. Army Veteran who was deployed to 
Afghanistan from 2005 – 2007. As a transportation and logistics specialist, 
Sam often travelled within the combat theatre as part of armoured vehicle 
convoys. During one mission in late 2006, the vehicle within which Sam 
was riding was hit by an improvised explosive device (IED) and several of 
Sam’s fellow members were significantly injured by shrapnel and 
concussive forces. Sam recalls feeling frightened and distressed at the 
time of this event but was able to serve the remainder of his deployment 
without any clinically significant consequences. Upon his return to the 
States in 2007, Sam reported to the PTSD clinic with PTSD symptoms 
most notably increased physiological and emotional arousal when driving 
or riding in a motor vehicle. Sam was treated with a few cognitive 
behavioural therapy regimens including cognitive processing therapy (CPT) 
and prolonged exposure (PE) therapy with varying degrees of success 
reported by Sam. Sam recalled that an aspect of cognitive therapy that was 
helpful was learning new ways to think about traumatic events and their 
aftermath. Over the course of therapy, Sam recognized that the sights, 
sounds, and smells (i.e., cues) present during his travels on American 
roads were qualitatively different from those that were present in 
Afghanistan. In addition, there was a clear familiarity of the roads he 
traveled at home. These factors provided a sense of safety for Sam, and 
as he progressed through treatment, the safety inherent with traveling by 
vehicle in the States transferred to his experiences of being in a car 
(initially reported by Sam to be a reminder of a Humvee cabin) and sitting 
in U.S. road traffic (initially reported by Sam to remind him of a military 
convoy). From a learning theory perspective, the reduction in Sam’s 
reactivity to motor vehicle cues over time represents a form of fear 
inhibition in which the inhibitory properties of a safety signal are transferred 
to a danger signal that previously evoked fear. 
 As discussed in section 2.6, Sam’s ability to reduce his fearful 
responses to riding in a motor vehicle at home following his vehicle-based 
traumatic event while deployed can also be explained, to some degree, by 
reversal learning. Reversal learning occurs when an individual successfully 
determines that a cue that previously predicted a negative outcome later 
predicts a neutral or positive outcome. In Sam’s case, the cue (i.e., motor 
vehicle) remained largely constant but the context (i.e., United States 
versus Afghanistan) qualitatively changed. The study of reversal learning in 
PTSD populations is in its infancy but represents a potential area of 
increased focus for clinical interventions. 
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the contexts in which these cues are presented (Norrholm and Jovanovic, 2018; VanElzakker 
et al., 2013). In addition to the extinction phenomena discussed previously, an emerging area 
of interest with regard to PTSD and clinically-relevant learning mechanisms is reversal 
learning. In a typical reversal learning procedure, participants learn that the valence (i.e., 
positive or negative outcome) of a paired association between cue and context initially 
predicts a neutral or aversive consequence (e.g., cue A is followed by a US). Subsequently, 
this reinforced cue is then presented with a different, often positive, outcome on later trials. 
To successfully learn the new associations presented in a reversal learning paradigm, 
participants need to reverse their association expectation of either the original cue or original 
context while keeping the valence of the other dimension constant to isolate reversal learning 
on a single dimension (cue or context). 
 The potential validity of increased focus on reversal learning was illustrated in a 
recent study by Levy-Gigi et al. (2014) who assessed this type of learning in trauma-exposed 
firefighters, crime scene investigators, and non-traumatized control participants. As described 
above, the authors presented reversal associations of cue and context independently and 
tested the ability of each group to learn the contingency reversals. Previously traumatized 
firefighters exhibited a decreased capacity to learn that a context that initially predicted a 
negative outcome, when presented with a different cue, was subsequently followed by a 
positive outcome. Conversely, previously traumatized crime scene investigators showed an 
impaired ability to learn that a cue that initially predicted a negative outcome when the 
context remained constant. The authors discuss these results in terms of the specific 
occupation-related tasks required by each of these professions; firefighters may be more 
attuned to contextual features of the environments to which they are exposed whereas crime 
scene investigators may recruit more discrete cue-specific features of the contexts within 
which they work. The results of this work suggest that clinical focus, as it relates to the fear-
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related symptoms of trauma-, stressor-, and anxiety-related disorders should not be limited to 
fear-related cues, or triggers, but also the multiple contexts within which they appear. 
 
2.7. Avoidance and Avoidance Extinction 
While deficits in the learning and memory for fear extinction is one mechanism by 
which fear might persist, another is avoidance. Avoidance refers to any active or passive 
behavior that increases the distance between an individual and an aversive event or situation 
(for an excellent review, see Pittig et al., 2018). In relation to PTSD, this typically involves 
reminders of a traumatic event. For example, an individual involved in a nasty cycling 
accident on an ordinary stretch of road may actively avoid that area to prevent anxious 
thoughts and feelings about the potential for another accident, or to avoid memories of the 
previous accident. Avoidance behaviors are a common technique of managing symptoms in 
anxiety disorders due to the direct negative reinforcement of reducing anxious thoughts and 
feelings (LeDoux et al., 2017; Mineka, 1979). This, however, leads to a distorted ability to 
recognize safe vs. dangerous situations, and becomes a maladaptive strategy of managing 
symptoms (LeDoux et al., 2017). Maladaptive avoidance behaviors can lead to a flow-on 
effect of additional comorbidities with PTSD, as Possemato et al. (2015) found that greater 
use of maladaptive avoidance-based coping strategies was associated with an increased risk 
of alcohol use in veterans with PTSD. For an account of various theoretical explanations of 
avoidance behaviors in associative and instrumental learning paradigms, see Lovibond 
(2006). 
Avoidance paradigms typically begin with a Pavlovian conditioning phase, followed 
by an avoidance phase. During instrumental avoidance tasks, participants are presented with 
an additional cue indicating the CS+ can be avoided (e.g., via a spacebar press, or multiple 
rapid presses). Research in healthy controls shows that when an extinction phase follows 
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avoidance training, the presentation of an avoidance cue during extinction prevents 
participants from extinguishing, known as ‘protection from extinction’ (Lovibond et al., 
2009). The act of initiating the avoidance cue arbitrarily removes any expectancy of the US, 
and extinction therefore cannot occur (Lovibond et al., 2009). Recent evidence in healthy 
controls also shows that greater reinforcement of avoidance (i.e., higher chance that 
avoidance behaviors will cancel the US) results in persistent fear responses throughout an 
extinction learning phase (Xia et al., 2017).  
In clinically ecological paradigms, there is evidence that individuals with greater 
levels of anxiety show increased instrumental avoidance behaviors to reduce the likelihood of 
experiencing the aversive US. Dymond et al. (2014) found that individuals with high spider 
fear require fewer acquisition trials to develop an avoidance response to an image of a spider, 
compared to individuals with lower levels of spider fear. Further, anxious children in a 
choice-based fear learning task are more likely to choose a safety signal instead of a threat 
signal, indicating avoidance of threat (Lau and Viding, 2007). Avoidance symptoms in 
veterans with PTSD also show associations with neural networks of emotion during fear 
conditioning and extinction (Sripada et al., 2013).  
During exposure therapy for PTSD and other anxiety disorders, initial reports 
suggested that within- and between-session habituation of physiological arousal/anxiety is 
necessary for long-term symptom reduction (Foa and Kozak, 1986). That is, disrupting the 
habituation process during the session when anxiety levels become too high was viewed as a 
form of negative reinforcement, promoting avoidance and ongoing symptoms. Recent 
reports, however, suggest that within-session habituation does not predict behavioral 
avoidance at follow-up (Craske et al., 2008; Kircanski et al., 2012). These findings indicate 
some uncertainty regarding how avoidance might be targeted during the treatment process, 
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however it is likely that the natural recovery from negative posttraumatic stress reactions may 
be ‘protected’ by the use of avoidance behaviors (Lovibond et al., 2009). 
 
2.8. Fear Generalization 
 An important experimental and clinical understanding is that conditioned fear and 
arousal can be caused by stimuli that were not present during a traumatic event (Dymond et 
al., 2015). The concept of generalization refers to the extension of conditioned responses to 
stimuli that may be perceptually, symbolically, or contextually related to the original CS (for 
a review of different generalization techniques, see Dymond et al., 2015). Recent 
investigations show reduced vmPFC-amygdala connectivity to generalized stimuli 
resembling the safety signal in patients with PTSD, compared to controls (Morey et al., 
2015). Indeed, Lissek et al. (2013) found that healthy participants show greater hippocampal-
vmPFC connectivity in a gradient-response relationship with generalization stimuli as the 
stimuli show a closer perceptual relationship with the safety signal (the neural mechanisms of 
fear generalization in relation to PTSD are reviewed in Lopresto et al., 2016). While little 
research has investigated classically conditioned fear generalization in PTSD, this model has 
important clinical relevance for the development and persistence of anxious symptoms 
(Lissek, 2012), as patients with PTSD frequently generalize anxiety and fearful responses to 
safe stimuli that were not present during the trauma.  
 
2.9. Summary 
 While empirical research of some of these experimental paradigms is limited in 
clinical samples, these models nonetheless provide important explanations for a variety of 
fear-related features of PTSD and other anxiety disorders. As summarized in Table 1, the 
biological and experimental models outlined above provide unique descriptions for the 
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development and persistence of fear-related symptoms (via conditioning, impaired extinction, 
and over-generalization mechanisms), treatment and the maintenance of treatment responses 
(extinction learning and recall mechanisms), the post-treatment relapse of symptoms (return 
of fear paradigms), avoidance behaviors of trauma-related stimuli (via instrumental 
avoidance paradigms), and fearful responding to safe stimuli (via inhibition and 
generalization paradigms). As highlighted at the beginning of this review, PTSD is a complex 
psychiatric conditioning with significant variability in symptom presentation. As such, the 
above sections are directed at explaining the clinical relevance of these paradigms for the 
fear-related features of PTSD (see Figure 2). 
 
Table 1 
The applications and relevance of conditioning paradigms for behavioral and clinical 
situations. 
Conditioning paradigms Behavioral/clinical analogues 
Fear acquisition The development of conditioned anxiety- and fear-provoking 
triggers. 
Fear extinction learning When unimpaired = natural recovery. 
When impaired = symptom persistence. 
Important mechanism of exposure-based treatment. 
Fear extinction recall When unimpaired = symptom improvement. 
When impaired = poor between-session treatment response. 
Important mechanism of exposure-based treatment 
Return of fear Post-treatment relapse of symptoms. 
Fear inhibition Impaired ability to transfer learned safety contingencies. 
Important mechanism of exposure-based treatment. 
Reversal learning New learning that a previously threatening stimulus/context 
signals safety. 
Avoidance Active maintenance of symptoms. Protection from recovery. 
Fear generalization Symptom persistence and the transfer of conditioned 
fear/anxiety to different (but perceptually or conceptually 
similar) stimuli. 
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[INSERT FIGURE 2 ABOUT HERE] 
 
3. Mediators and Moderators of Conditioning and Extinction Processes 
 The aforementioned sections have detailed different paradigms of Pavlovian fear 
learning, and their direct clinical relevance in the development, treatment, and relapse of 
PTSD symptoms. In addition, there has been increased attention toward identifying various 
boundary conditions of fear learning, with important implications for theory development and 
the treatment of fear-related symptoms. For example, a large body of research shows 
significant effects of sleep quality on fear extinction potential (reviewed in Pace-Schott et al., 
2015a, b), and therapies targeting nightmares also improve PTSD symptoms (Krakow et al., 
2001). Sleep quality, therefore, appears to act as a moderator (or mediator) of fear extinction 
learning, and treatment response might be enhanced by also focusing on a patients’ quality of 
sleep. In the following section, we briefly review the evidence of known moderators and 
mediators of Pavlovian fear learning. As this section covers a number of rich research areas, 
this section is brief, with appropriate acknowledgement to the relevant reviews of many of 
these fields. Similarly, the central role that fear extinction learning and memory appears to 
play in linking many of these fields of research to PTSD has been reviewed previously (Zuj 
et al., 2016b).  
 
3.1. Genetic Mechanisms 
 Due to increases in our scientific capacity to measure the influences of genetics for 
biological and hormonal processes, the study of genetics is argued to be a key method 
moving forward for understanding PTSD risk (Zoladz and Diamond, 2013) and processes of 
fear conditioning memories (Johnson et al., 2012). In brief, PTSD and fear extinction have 
each been identified to show relationships with brain-derived neurotrophic factor (BDNF), 
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catechol-O-methyltransferase (COMT), serotonin transporter genes, FK binding protein 5 
(FKBP5), among others. Importantly, many of the aforementioned genotypes show a similar 
relationship with PTSD and fear conditioning/extinction processes both independently and, 
more recently, simultaneously (reviewed in Zuj et al., 2016b).  
BDNF is involved in the synaptic plasticity of the emotional circuitry of the brain 
(namely the amygdala, PFC, and hippocampus), and higher serum BDNF levels have been 
associated with greater PTSD symptom severity (Hauck et al., 2009; Hauck et al., 2010; 
Matsuoka et al., 2013; Rakofsky et al., 2012). Additionally, carriers of the Met allele of the 
BDNF Val66Met polymorphism show poor response to exposure therapy (Felmingham et al., 
2013) and poorer extinction learning (Soliman et al., 2010). Recently, Felmingham et al. 
(2018) found the BDNF Val66Met polymorphism to be a significant moderator between 
PTSD symptoms and extinction learning, with greater PTSD symptoms and poorer fear 
extinction only in Met allele carriers, but not Val carriers.  
 COMT is an enzyme involved in the synaptic degradation of dopamine, epinephrine, 
and norepinephrine within the PFC and hippocampus (Bomyea et al., 2012). Homozygosity 
of the Val158Met polymorphism (Val/Val or Met/Met carriers) is associated with greater and 
lower levels of dopamine degradation, respectively (Tunbridge et al., 2006). In comparison, 
Val/Met carriers appear to show balanced dopamine degradation at the synapse. There is 
consistent evidence that homozygous Val/Val or Met/Met carriers show greater PTSD 
symptoms than heterozygous Val/Met carriers (Boscarino et al., 2011; Clark et al., 2013; 
Deslauriers et al., 2018; Kolassa et al., 2010; Valente et al., 2011). COMT Val158Met 
homozygosity is also associated with impaired fear extinction (Lonsdorf et al., 2009) and fear 
inhibition to safety signals (Deslauriers et al., 2018; Norrholm et al., 2013; Wendt et al., 
2014). 
27 
 Studies indicate that carriers of the ‘short’ allele of the serotonin transporter gene, 5-
HTTLPR, show stronger conditioned fear responses during acquisition (Hermann et al., 
2012; Lonsdorf et al., 2009). In clinical situations, the 5-HTTLPR-s allele also shows 
significant gene × environment interactions to increase risk for PTSD. Specifically, 5-
HTTLPR-s shows significant associations with high trauma exposure and interpersonal 
experiences (e.g., low social support) to increase risk for PTSD (Gressier et al., 2013; 
Kilpatrick et al., 2007; Koenen et al., 2009). Although, Wald et al. (2013) found that in the 
military, the 5-HTTLP-s allele interacted with increased combat exposure and attentional 
threat biases as protective factors for PTSD. 
 FK506 binding protein 5 (FKBP5) is important in modulating glucocorticoid receptor 
sensitivity, influencing the activity of cortisol and the negative feedback loop of the 
hypothalamic-pituitary-adrenal axis (Bomyea et al., 2012; Zannas and Binder, 2014). 
Research suggests that, similar to the 5-HTTLPR-s allele, FKBP5 is not associated with 
PTSD risk in isolation (Binder et al., 2008; Xie et al., 2010), but interacts with childhood 
trauma to increase risk for PTSD (Xie et al., 2010). Specifically, the RS9470080 SNP of 
FKBP5 has been associated with childhood trauma as a G×E risk for PTSD (Xie et al., 2010), 
but has also been associated with hyperarousal symptoms and impaired extinction learning in 
a sample with PTSD (Galatzer-Levy et al., 2017). Rodent models of PTSD have also shown 
that reduced fear acquisition and enhanced fear extinction learning and memory are 
associated with reduced FKBP5 expression in the amygdala (Sawamura et al., 2016) and the 
infralimbic cortex (Criado-Marrero et al., 2017). The biological processes relating FKBP5 to 
fear memory and PTSD have been reviewed by Maddox et al. (2013) 
 
3.2. Biological Mechanisms 
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 The hormonal stress response can be simply described in terms of two systems: (1) 
the sympathetic nervous system, releasing fast-acting catecholamines such as adrenaline and 
noradrenaline; and (2) the hypothalamic-pituitary-adrenal (HPA) axis, which is a slow-
response system regulating the stress response of the sympathetic nervous system, and acting 
to return physiological systems to pre-threat levels (for a review, see Szeszko et al., 2018). 
Individuals with PTSD have been shown to display elevated noradrenaline levels, relative to 
controls (Geracioti et al., 2001; Pietrzak et al., 2013; Wingenfeld et al., 2015; Yehuda et al., 
1998; Yehuda et al., 1992; although see Zuj et al., 2018). Noradrenaline is considered an 
important modulator of emotional memory consolidation (Mueller and Cahill, 2010), and 
rodent studies show yohimbine administration (resulting in increased noradrenaline secretion) 
immediately prior to extinction learning results in enhanced extinction (Cain et al., 2004; 
Morris and Bouton, 2007). Similarly, yohimbine administration immediately prior to 
conditioning in human subjects results in a conditioned fear that is resistant to extinction 
(Soeter and Kindt, 2012). Using behavioral tests, such as a cold presser test, immediately 
before acquisition or extinction learning results in stronger conditioned fear or enhanced 
extinction learning, respectively (Antov et al., 2015; Antov et al., 2013). Zuj et al. (2018), 
however, recently found that the relationship between extinction learning and PTSD 
symptom severity does not change as a factor of endogenous salivary α-amylase (as a proxy 
for noradrenaline levels), suggesting that the relationship between conditioning/extinction, 
PTSD, and noradrenaline is unclear. 
Evidence has been somewhat inconsistent regarding PTSD-related cortisol secretion, 
with research showing persistent PTSD to be associated with increased cortisol (Groer et al., 
2014), reduced cortisol (Bicanic et al., 2013; Wahbeh and Oken, 2013; Yehuda et al., 2009; 
Yehuda et al., 2007a; Yehuda et al., 2007b), or no differences, compared to control groups 
(Shalev et al., 2008; Zuj et al., 2017c). A meta-analysis conducted by Morris et al. (2012), 
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however, found that PTSD appears to be associated with lower cortisol secretion compared to 
control groups (after controlling for extraneous variables). Regarding conditioning research, 
cortisol appears to be more closely related to the inhibition of responses. That is, cortisol may 
affect the ability to accurately inhibit responses to safe stimuli that do not pose a threat. 
Recently, Zuj et al. (2017c) found that cortisol reactivity (from baseline to US-exposure) was 
a significant moderator between PTSD and responding to the CS-. Specifically, higher 
cortisol reactivity – but not lower reactivity – was associated with lower PTSD symptom 
severity as fear inhibition increased. Following release, cortisol binds to glucocorticoid 
receptors and studies have shown that glucocorticoid administration facilitates extinction 
(Barrett and Gonzalez-Lima, 2004; Cai et al., 2006; de Quervain et al., 2009; Yang et al., 
2006). 
Women are almost twice as likely to develop PTSD compared to men (e.g., Glover et 
al., 2015), and research implicates the sex hormones estrogen and progesterone in this 
process, albeit inconsistently. For example, women who were exposed to a traumatic event 
during the luteal phase of the menstrual cycle (associated with elevated estrogen and 
progesterone) developed stronger intrusive memories of the trauma (Bryant et al., 2011). 
Similarly, women with PTSD have also shown impaired fear extinction recall during the mid-
luteal phase compared to women without PTSD (Pineles et al., 2016). Alternatively, research 
in healthy women has found low estrogen levels to be associated with poorer extinction 
learning (Wegerer et al., 2014), extinction recall (Milad et al., 2010; Zeidan et al., 2011), and 
fear inhibition (Glover et al., 2013). Glover et al. (2012) also found that women with PTSD 
and low estrogen levels demonstrated poorer extinction learning compared to trauma-exposed 
controls. As such, while research clearly indicates an important role for the menstrual cycle 
and sex hormones as a mechanism/boundary condition of sex differences in extinction 
learning and memory, the nature of this relationship is currently unclear. 
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3.3. Behavioral Mechanisms 
Sleep is considered a crucial mechanism of emotional memory consolidation 
(Stickgold, 2005), including the process of recovery from PTSD (Germain, 2013). Numerous 
studies indicate that sleep quality has a significant impact on fear extinction learning and 
memory (for reviews on the topic, see Pace-Schott et al., 2015a, b). Specifically, evidence 
shows that fear extinction memories generalize to previously conditioned but unextinguished 
stimuli (Pace-Schott et al., 2009). Extinction learning, memory, and generalization are also 
more effective in the morning compared to the evening (Pace-Schott et al., 2013), and this 
effect is stronger in participants with PTSD compared to trauma-exposed and non-exposed 
controls (Zuj et al., 2016a). In clinical situations, greater pre-trauma sleep disturbances are 
also shown to predict the development of PTSD (Bryant et al., 2010), and greater sleep 
disturbances also slow the rate of recovery via cognitive therapy for PTSD in those with 
comorbid depression (Lommen et al., 2016). Indeed, Lommen et al. (2016) found cognitive 
therapy improved sleep quality and reduced PTSD symptoms simultaneously, highlighting 
the important relationship between the two factors. 
Prevalence rates show elevated levels of smoking in those with anxiety disorders 
(Lasser et al., 2000), with smoking being a significant predictor of post-treatment symptom 
return in PTSD and other anxiety disorders (Taylor et al., 2015). Rodent studies show that 
nicotine administration results in impaired contextual safety discrimination (Kutlu et al., 
2014) and facilitates the spontaneous recovery of previously extinguished stimuli (Kutlu et 
al., 2016). Recent work by Haaker et al. (2017) in mentally healthy controls showed impaired 
within-session fear extinction was correlated with the frequency and chronicity of smoking, 
and smokers displayed impaired extinction recall the following day compared with non-
smokers. A number of studies examining smoking behaviors in PTSD have revealed periods 
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of abstinence are met with stronger cigarette cravings in PTSD (Beckham et al., 2013; Dedert 
et al., 2012), and that trauma reminders may also signal strong cravings (Beckham et al., 
1996). Research also shows that individuals with PTSD attempting to quit experience sooner 
lapses of smoking compared to non-PTSD quitting smokers, and this is attributed to negative 
affect and trauma reminders (Beckham et al., 2013). Aforementioned rodent studies suggest 
that smoking may impair fear extinction learning ability in humans (for a review, see Kutlu 
and Gould, 2015), and this may translate to response to exposure treatment in PTSD.  
 
3.4 Cognitive Mechanisms 
 PTSD has been described as a disorder of memory (McNally, 2006), often involving 
fragmented and intrusive memories of the traumatic event, and conditioning and extinction 
are important forms of emotional memory in PTSD. In a meta-analysis, Brewin et al. (2007) 
determined that the most consistent cognitive domain affected in PTSD is verbal learning and 
memory. Indeed, reductions in PTSD symptom severity is also associated with increases in 
verbal learning and memory (Yehuda et al., 2006). Recently, Gazendam and Kindt (2012) 
instructed participants to engage in a verbal worrying task, showing that the verbal task was 
associated with significantly poorer extinction than a control task. Research has also shown 
that conditioning and extinction are dependent on available cognitive resources, with greater 
demands on working memory systems resulting in reduced conditioning (Carter et al., 2003) 
and impaired extinction (Raes et al., 2009). Finally, recent research has found that conscious 
cognitive awareness of the US-CS+ contingency is essential for conditioning of SCR, but not 
startle (Sevenster et al., 2014), suggesting an important role of cognitive load and the 
availability of cognitive resources in appropriate conditioning and extinction. 
  
4. Conclusion 
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 In the present review, we discuss a number of paradigms of human fear learning, and 
highlight the relevance and applications of these paradigms for the fear-related features of 
PTSD. In doing so, we have discussed the applications of these paradigms for the 
development, maintenance, normal and treatment-assisted recovery of symptoms, as well as 
the post-treatment relapse of PTSD symptoms. To illustrate the applicability of these 
paradigms, we have provided a real-world case example of a patient with severe PTSD 
symptomatology. While PTSD is associated with additional features that cause significant 
reductions in daily functioning and quality of life (e.g., anger and dissociation), the current 
review aimed to provide explanations for various aspects of fear-related symptoms (e.g., 
avoidance behaviors and hyperarousal). While some of these paradigms have been studied 
extensively in PTSD patients (e.g., conditioning, extinction, and inhibition), other paradigms 
have been involved in limited studies with clinical populations (e.g., avoidance and 
generalization). Finally, we have provided a brief review of some of the biological, 
behavioral, and cognitive variables that are known to influence PTSD symptoms and the fear 
conditioning/extinction process, and may be important in therapy for PTSD. 
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